Dr. Jay S. Duker, M.D.

Dr. Jay S. Duker, M.D., serves on the Aldeyra Therapeutics Retina Scientific Advisory Board and is the Director of the New England Eye Center (NEEC), one of the largest academic, multi-specialty ophthalmology practices in the United States.  He is also Professor and Chairman of the Department of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine in Boston. Dr. Duker received his medical degree magna cum laude from Jefferson Medical College. He completed both his ophthalmology residency and his two year fellowship in vitreo-retinal diseases at the Wills Eye Hospital in Philadelphia. His clinical practice is limited to medical and surgical diseases of the posterior segment with particular emphasis on macular diseases, posterior uveitis and intraocular tumors.

Dr. Duker has published over 250 journal articles, with his major research interests, which include retinal imaging and in particular, optical coherence tomography (OCT), retinal vascular diseases and drug delivery to the posterior segment. His book, Yanoff and Duker’s Ophthalmology, is one of the best-selling ophthalmic texts over the past decade. He is the editor-in-chief of the International Journal of Retina and Vitreous (IJRV) and serves on the editorial board of OSLI Retina. Dr. Duker is the co-founder of three companies, including Hemera Biosciences, a clinical stage biotech whose focus is a gene-therapy-based treatment for age-related macular degeneration. He is also a Director of two publicly traded biotech companies –  Eleven Biotherapeutics, a clinical-stage targeted protein engineering company concentrating on oncologic indications and pSivida which specializes in sustained release drug delivery.